Table of Contents 3
List of Tables 5
List of Figures 5
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
La Jolla Pharmaceutical Company, Medical Devices Deals, 2012 to YTD 2018 10
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
La Jolla Pharma to Acquire Rights to Gentamicin Derivatives from IURTC 13
La Jolla Pharma Acquires GCS-100 From Solana Therapeutics 14
Licensing Agreements 15
La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 15
IURTC Enters into Licensing Agreement with La Jolla Pharma 16
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 17
La Jolla Pharma Enters into Licensing Agreement with George Washington University 18
La Jolla Pharma Enters Into Option For Licensing Agreement With George Washington University 19
Equity Offering 20
La Jolla Pharma Files Registration Statement for USD150 Million in Public Offering 20
La Jolla Pharmaceutical Raises USD125 Million in Underwritten Public Offering of Shares 21
La Jolla Pharma Prices Public Offering of Shares for USD100 Million 23
La Jolla Pharma Raises USD111.4 Million in Public Offering of Shares 24
La Jolla Pharma Raises USD56.6 Million in Public Offering of Shares 26
La Jolla Pharma Completes Private Placement Of Shares For US$6.7 Million 28
La Jolla Pharma Completes Private Placement Of Preferred Stock For US$3.3 Million 29
La Jolla Pharmaceutical Company - Key Competitors 30
La Jolla Pharmaceutical Company - Key Employees 31
La Jolla Pharmaceutical Company - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Oct 24, 2018: La Jolla Pharmaceutical Company Reports Financial Results for the Three and Nine Months Ended September 30, 2018 33
Aug 08, 2018: La Jolla Pharmaceutical company announces financial results for the three and six months ended June 30, 2018 and recent corporate progress 34
May 10, 2018: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress 35
Feb 22, 2018: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress 37
Oct 26, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress 38
Jul 27, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress 39
Apr 27, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress 40
Feb 23, 2017: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Progress 41
Product News 42
09/13/2017: Researchers Develop New Strategy to Target KRAS Mutant Cancer 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Key Facts, 2017 2
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
La Jolla Pharmaceutical Company, Deals By Therapy Area, 2012 to YTD 2018 9
La Jolla Pharmaceutical Company, Medical Devices Deals, 2012 to YTD 2018 10
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
La Jolla Pharma to Acquire Rights to Gentamicin Derivatives from IURTC 13
La Jolla Pharma Acquires GCS-100 From Solana Therapeutics 14
La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 15
IURTC Enters into Licensing Agreement with La Jolla Pharma 16
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 17
La Jolla Pharma Enters into Licensing Agreement with George Washington University 18
La Jolla Pharma Enters Into Option For Licensing Agreement With George Washington University 19
La Jolla Pharma Files Registration Statement for USD150 Million in Public Offering 20
La Jolla Pharmaceutical Raises USD125 Million in Underwritten Public Offering of Shares 21
La Jolla Pharma Prices Public Offering of Shares for USD100 Million 23
La Jolla Pharma Raises USD111.4 Million in Public Offering of Shares 24
La Jolla Pharma Raises USD56.6 Million in Public Offering of Shares 26
La Jolla Pharma Completes Private Placement Of Shares For US$6.7 Million 28
La Jolla Pharma Completes Private Placement Of Preferred Stock For US$3.3 Million 29
La Jolla Pharmaceutical Company, Key Competitors 30
La Jolla Pharmaceutical Company, Key Employees 31
La Jolla Pharmaceutical Company, Subsidiaries 32

List of Figures
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
La Jolla Pharmaceutical Company, Medical Devices Deals, 2012 to YTD 2018 10